Treatment Registry

Molecule

Compounded orforglipron

1 recorded program. No comparable monthly price is verified. See the record for advertised amounts and conditions.

US route An FDA-approved orforglipron product exists, but a compounded preparation is not itself an FDA-approved product. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. A molecule listing does not establish whether an individual preparation meets applicable requirements. Classification recorded October 2026. FDA source. FDA information on compounded GLP-1 drugs. All orforglipron forms.

Entries

More columns to the right? Scroll across the table to see all details.

EntryProviderFormRecorded price
with its payment basis
Last verifiedLink
EntryTR-1206Not verifiedProviderMochi HealthFormOral · preparation details unconfirmedRecorded price$31Last verifiedNovember 2026Record

Historical recorded price · November 2026 · not currently verified

Published figure · Compounded orforglipron — advertised starting amount

Initial payment not verified

The renewal charge is not verified.

The compounded oral catalog advertises a starting amount; selected dose, supply, payment interval and full invoice are unconfirmed. Medication and membership are separate; individual eligibility and state availability remain unconfirmed.